Elsevier Introduces SciVerse Scopus Alerts Individual
Mobile app now also available to non-institutional subscribers
Amsterdam, October 6, 2011 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the availability of a new mobile application, SciVerse Scopus Alerts Individual, which provides non-institutional subscribers with immediate, on-the-go access to the latest Scopus content. While users based in subscribing institutions can already benefit from a free mobile app, this new service signifies an important increase in the range and flexibility of Scopus.
Through this new iPhone and Android application, individuals can now utilize key features of the world’s largest abstract and citation database. SciVerse Scopus Alerts Individual gives users the opportunity to search across thousands of scholarly journals from more than 5,000 international publishers. This is the first time Elsevier has offered any form of individual subscription to its flagship bibliographic database.
Among the key features of SciVerse Scopus Alerts Individual is the search and citation alerts function, which allows researchers to receive updates on new publications relevant to their fields of interest and notifications on citations of their work by peers. The mobile application also fosters collaboration among the research community as users can share links to articles with colleagues through an email function included in the app.
“For those who wish to stay connected in today’s competitive research landscape, leaving their work at the lab is no longer an option,” said Yukun Harsono, Senior Vice President, Search & Discovery at Elsevier. “By broadening the availability of Scopus through a mobile application to individuals who do not receive subscriptions through their institutions already, more researchers and librarians are able to keep their work at their fingertips, wherever their work takes them.”
SciVerse Scopus Alerts Individual is available to non-institutional subscribers for a 30-day free trial and subsequently a yearly fee. It is available globally through the iTunes store and for Android devices through AndroidMarket.
For existing institutional subscribers the free SciVerse Scopus Alerts App for iPhone, Android or Blackberry will remain available.
For more information on SciVerse Mobile Applications, go to http://www.info.sciverse.com/sciverse-mobile-applications.
# # #
About SciVerse Scopus
Covering the world's research literature, SciVerse Scopus ( http://www.info.sciverse.com/scopus) is the largest abstract and citation database of peer-reviewed literature and quality Web sources with smart tools to track analyze and visualize research. SciVerse Scopus was designed and developed with over 500 users and librarians internationally. Its unique database contains abstracts and references from nearly 18,000 peer-reviewed journals from 5,000 publishers worldwide, ensuring broad interdisciplinary coverage. In addition, SciVerse Scopus not only offers users citation information about the articles covered, but also directly integrates Web and patent searches. Direct links to full-text articles, library resources and other applications like reference management software, make SciVerse Scopus quicker, easier and more comprehensive to use than any other literature research tool.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and 25,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby’s Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contact
+ 1 212 752 8338